We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Boston Scientific stock rose April 6 after the devicemaker won antitrust clearance from the Federal Trade Commission (FTC) for its $27 billion acquisition of former rival Guidant, whose shares also rose, according to published reports.
Andrx and Takeda Pharmaceuticals have filed a new drug application (NDA) for a combination product to treat Type 2 diabetes, the companies said April 4.
Icelandic generic company Actavis plans to buy Romanian generic drugmaker Sindan for $177 million cash, the latest in a string of acquisitions for Actavis.
Indian generic drugmakers acquiring European generic firms hope to profit by combining European drug distribution networks with cheaper Indian manufacturing capabilities, according to one expert.
Bayer will bid to acquire Schering AG after that company's executive board rejected a takeover offer from Merck KGaA, according to the three companies.